4/A//SEC Filing
REPROS THERAPEUTICS INC. 4/A
Accession 0001181431-08-017636
CIK 0000897075operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 6:05 PM ET
Size
6.7 KB
Accession
0001181431-08-017636
Insider Transaction Report
Form 4/AAmended
CAIN DANIEL F
Director
Transactions
- Award
Stock Option (right to buy)
2007-05-15+5,000→ 5,000 totalExercise: $12.37Exp: 2017-05-14→ Common Stock (5,000 underlying)
Holdings
- 2,000
Common Stock
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 100% of the shares subject to the option upon the Annual Meeting of the Stockholders of the issuer following the date of grant so long as the Reporting Person remained a director of Repros Therapeutics Inc. up to the date of the Annual Meeting.
Documents
Issuer
REPROS THERAPEUTICS INC.
CIK 0000897075
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000897075
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 6:05 PM ET
- Size
- 6.7 KB